Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolv Technologies Holdings (EVLV) Research & Development (2020 - 2025)

Evolv Technologies Holdings' Research & Development history spans 6 years, with the latest figure at $5.4 million for Q4 2025.

  • For Q4 2025, Research & Development changed 0.41% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $21.8 million, down 7.05%, while the annual FY2025 figure was $20.6 million, 12.06% down from the prior year.
  • Research & Development for Q4 2025 was $5.4 million at Evolv Technologies Holdings, up from $4.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $6.4 million in Q3 2023 and bottomed at $3.6 million in Q3 2021.
  • The 5-year median for Research & Development is $5.4 million (2024), against an average of $5.3 million.
  • The largest annual shift saw Research & Development skyrocketed 54.24% in 2022 before it dropped 21.64% in 2025.
  • A 5-year view of Research & Development shows it stood at $3.6 million in 2021, then increased by 26.06% to $4.6 million in 2022, then skyrocketed by 36.95% to $6.3 million in 2023, then dropped by 14.25% to $5.4 million in 2024, then increased by 0.41% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for EVLV's Research & Development are $5.4 million (Q4 2025), $4.9 million (Q1 2025), and $5.4 million (Q4 2024).